Why has FMC (FMC) increased by 4.5% following its most recent earnings announcement?

FMC Stock Outperforms S&P 500 in Recent Weeks

Over the past month, FMC shares have climbed approximately 4.5%, surpassing the performance of the S&P 500 index.

Will FMC's Upward Momentum Last?

Investors may be questioning whether FMC's recent gains will persist as the next earnings report approaches, or if a correction is on the horizon. Before analyzing recent market and analyst reactions, let's review the company's latest financial results to better understand the key factors at play.

Fourth Quarter Results: Earnings and Revenue Miss Expectations

For the fourth quarter of 2025, FMC posted a net loss of $13.74 per share, a significant increase from the $0.13 loss reported in the same period last year.

Excluding special items, adjusted earnings per share came in at $1.20, down from $1.79 a year earlier and slightly below the Zacks Consensus Estimate of $1.21.

Quarterly revenue totaled about $1.08 billion, representing an 11.5% decrease year-over-year and falling short of the consensus estimate of $1.15 billion.

The decline in revenue was primarily driven by substantial price reductions, especially for Rynaxypyr, and heightened competition for core products in Latin America, which led to lower sales volumes.

Sales Performance by Region

• North America: Sales rose 3% year-over-year to $350.5 million, fueled by increased demand for herbicides, fungicides, and strong growth in fluindapyr. This result exceeded the consensus estimate of $346.7 million.
• Latin America: Revenue dropped 5% to $371.1 million, impacted by greater competition from generic products, which pressured both volumes and branded product prices. This figure was below the expected $416.3 million.
• Asia (excluding India): Sales fell 41.1% to $180.7 million, mainly due to adverse weather and lower branded product prices, missing the $186.3 million estimate.
• EMEA: Revenue declined 2% to $183.8 million, with unfavorable weather and weaker grower economics leading to reduced volumes. This result was below the consensus estimate of $196.9 million.

Financial Position

At the end of the quarter, FMC reported cash and cash equivalents of $584.5 million, with long-term debt standing at approximately $2.77 billion.

Outlook and Strategic Initiatives

For the first quarter, FMC anticipates revenue between $725 million and $775 million, representing a 5% decrease at the midpoint compared to the prior year. Adjusted EBITDA is projected to range from $45 million to $55 million, a 58% drop at the midpoint, while adjusted loss per share is expected to be between $0.32 and $0.44, a year-over-year decline of $0.56 at the midpoint.

For the full year, revenue is forecasted between $3.6 billion and $3.8 billion, a 5% decrease at the midpoint. Adjusted EBITDA is expected to fall to $670-$730 million, down 17% at the midpoint, and adjusted EPS is projected between $1.63 and $1.89, a 41% decrease at the midpoint compared to the previous year.

FMC also outlined its strategic goals for 2026 and announced that its board is considering various strategic alternatives, including the potential sale of the company.

Recent Estimate Revisions

Over the past month, analyst estimates for FMC have trended downward, resulting in a consensus estimate revision of -419.61%.

VGM Score Overview

• Growth Score: B
• Momentum Score: F
• Value Score: A (placing it among the top 20% for value-focused strategies)

FMC's overall VGM Score is B, making it a notable pick for investors who prefer a balanced approach rather than focusing on a single strategy.

Stock Outlook

With estimates continuing to move lower and the magnitude of these changes significant, FMC currently holds a Zacks Rank #5 (Strong Sell). The stock is expected to deliver below-average returns in the coming months.

Industry Comparison: Archer Daniels Midland (ADM)

FMC operates within the Zacks Agriculture - Operations industry. Over the last month, Archer Daniels Midland (ADM), another company in the sector, has gained 1.7%. ADM released its quarterly results for the period ending December 2025 over a month ago.

ADM reported quarterly revenue of $18.56 billion, a 13.7% year-over-year decrease, and earnings per share of $0.87, down from $1.14 in the prior year.

For the current quarter, ADM is expected to earn $0.71 per share, a 1.4% increase from the previous year. The consensus estimate for ADM has decreased by 3.8% over the past 30 days.

These estimate changes result in a Zacks Rank #3 (Hold) for ADM, which also carries a VGM Score of B.

Top Stock Picks from Zacks

The Zacks research team has identified five stocks with the potential to double in value in the coming months. Among these, Director of Research Sheraz Mian has spotlighted a lesser-known satellite communications company poised for significant growth as the space industry expands toward a trillion-dollar market. Analysts anticipate a major revenue surge for this company in 2025. While not all top picks achieve such results, this stock could outperform previous high achievers like Hims & Hers Health, which soared over 200%.